Deadline: 15-Jul-2026
Pfizer has announced a Competitive Fellowship Grant Program to support clinical training in transthyretin cardiac amyloidosis, also known as ATTR cardiac amyloidosis. The programme provides grant funding of up to €50,000 to German institutions to support one fellow for up to six months. The fellowship aims to strengthen healthcare professionals’ ability to recognize, diagnose, treat, monitor, and conduct research related to ATTR cardiac amyloidosis.
Overview
Pfizer’s Competitive Fellowship Grant Program supports institutional fellowship training in ATTR cardiac amyloidosis in Germany.
The programme is designed to build clinical and research capacity among healthcare professionals working in this specialized field.
Selected institutions will receive funding to support one fellow through structured clinical training, mentoring, patient management exposure, research development, and interdisciplinary learning.
Purpose of the Fellowship Grant
The purpose of the grant is to strengthen professional training in ATTR cardiac amyloidosis.
The fellowship helps healthcare professionals gain practical experience in recognizing, diagnosing, treating, monitoring, and researching ATTR cardiac amyloidosis.
It is intended to support clinical learning through direct involvement in patient care, case-based education, mentoring, and exposure to interdisciplinary approaches.
Key Focus Areas
The fellowship focuses on ATTR cardiac amyloidosis, clinical training, recognition of disease symptoms, diagnosis, treatment, monitoring, patient management, interdisciplinary learning, case-based education, research development, mentoring, diversity, equity and inclusion, and institutional capacity building in Germany.
What Is ATTR Cardiac Amyloidosis?
ATTR cardiac amyloidosis is a disease involving transthyretin amyloid deposits that affect the heart.
In the context of this fellowship, the condition is used as the central clinical training area for healthcare professionals who need deeper knowledge of patient care, diagnostic pathways, treatment approaches, monitoring needs, and research questions.
The fellowship is intended to help fellows develop an in-depth understanding of ATTR patient care through structured clinical and research training.
What the Fellowship Supports
The programme supports institutional fellowship training for one fellow.
Training activities may include:
- Clinical exposure to ATTR cardiac amyloidosis care
- Active participation in patient management
- Diagnosis and monitoring education
- Treatment-related training
- Case-based learning
- Interdisciplinary clinical discussions
- Research development activities
- Mentoring from experienced clinical and research professionals
- Training in patient-centered care approaches
The fellowship should be designed to provide both clinical knowledge and applied experience.
Funding Amount
Grant funding of up to €50,000 is available.
The grant may support one fellow for a period of up to six months.
Funding will be awarded directly to the institution and not to the individual fellow.
Eligible Use of Funds
Grant funds may only be used for the fellow’s salary and benefits.
The funding should not be used for unrelated institutional costs, equipment, travel, overheads, or activities outside the approved fellowship purpose unless specifically allowed by the official guidelines.
Who Is Eligible?
Eligible applicants are institutions located in Germany.
Institutions must have the capacity to deliver clinical training, mentoring, and research development in ATTR cardiac amyloidosis.
Applications must be submitted by the institution, not by an individual fellow.
Fellow Eligibility Requirements
Institutions should not name potential fellows in the application.
Any fellow supported through the programme must be a German worker.
This may include:
- German citizens
- Permanent residents
- Refugees
- Asylees
- Individuals holding an appropriate non-immigrant visa authorizing employment in Germany
The selected fellow will be identified in transparency reporting as a recipient of grant funding.
Institutional Requirements
Applicant institutions must demonstrate academic, clinical training, and research capacity.
Applications should describe:
- Institutional facilities
- Clinical resources available to the fellow
- Research resources
- Training environment
- Relevant experience in ATTR cardiac amyloidosis
- Past work related to the disease area
- Ability to support structured mentoring
- Capacity to manage the fellowship successfully
The institution should show that it can provide a strong environment for both clinical education and research development.
Mentoring Requirements
The fellowship must include a strong mentoring structure.
Applicants must describe:
- The mentoring process
- The role of the primary mentor
- The role of the secondary mentor, if applicable
- How mentors will support clinical training
- How mentors will support research development
- How progress will be assessed
- How the fellowship will support diversity, equity, and inclusion
A strong mentoring plan should show regular guidance, structured feedback, and clear learning objectives for the fellow.
Diversity, Equity and Inclusion Requirement
Applicants must explain how the fellowship promotes diversity, equity, and inclusion.
This may be demonstrated through:
- The fellow selection process
- The mentoring team
- Inclusive training practices
- Equal access to fellowship opportunities
- Supportive learning environments
- Fair and transparent selection procedures
The application should clearly connect diversity, equity, and inclusion to the fellowship design.
Required Application Materials
Applications must include a structured set of documents and information.
Required materials include:
- Cover page
- Fellowship title
- Participating institution details
- Abstract summarizing fellowship goals
- Training methods
- Research activities
- Assessment approach
- Description of mentoring process
- Description of clinical training structure
- Description of research development support
- Institutional facilities and resources
- Summary of relevant ATTR cardiac amyloidosis experience
- Identification of potential fellowship challenges
- Plan to address challenges
- Letter of support from the Division Head or Department Chair
- Letter of support from the primary mentor
- Letter of support from the secondary mentor, if applicable
Applicants should ensure that all materials are complete, clear, and consistent.
Why It Matters
ATTR cardiac amyloidosis requires specialized clinical knowledge for proper recognition, diagnosis, treatment, and monitoring.
Healthcare professionals need practical training to understand the full patient care pathway and to contribute to research in this field.
This fellowship matters because it helps institutions in Germany build capacity in ATTR cardiac amyloidosis care and research. By supporting structured training and mentoring, the programme can help improve professional expertise and strengthen patient-focused clinical practice.
How to Apply
Applicant institutions should prepare a complete fellowship proposal that explains the training structure, mentoring model, institutional capacity, and use of funds.
Step 1: Confirm Institutional Eligibility
The applicant must be an institution located in Germany.
The institution should confirm that it has the clinical, academic, and research capacity to train a fellow in ATTR cardiac amyloidosis.
Step 2: Design the Fellowship Structure
The application should describe how the six-month fellowship will be organized.
The structure should explain:
- Training objectives
- Clinical learning activities
- Patient management exposure
- Case-based education
- Interdisciplinary learning opportunities
- Research development activities
- Assessment methods
- Expected outcomes for the fellow
Step 3: Prepare the Mentoring Plan
Applicants must describe the mentoring process in detail.
The plan should include:
- Primary mentor responsibilities
- Secondary mentor responsibilities, if applicable
- Frequency of mentor meetings
- Clinical supervision approach
- Research guidance
- Feedback and assessment methods
- Fellow development milestones
Step 4: Demonstrate Institutional Capacity
The institution should describe the facilities, resources, and experience available to support the fellow.
This section should include:
- Clinical training environment
- Patient care exposure
- Research infrastructure
- Academic support
- Previous experience related to ATTR cardiac amyloidosis
- Relevant faculty or staff expertise
Step 5: Address Diversity, Equity and Inclusion
Applicants should explain how the fellowship will support diversity, equity, and inclusion.
This may include transparent fellow selection, inclusive mentoring, equitable access to training, or diverse mentor involvement.
Step 6: Identify Challenges and Solutions
The application should describe possible challenges during the fellowship and how the institution will manage them.
Possible challenges may include scheduling, patient exposure, research timelines, mentoring coordination, or fellow integration into clinical teams.
Step 7: Prepare the Budget
The budget may request up to €50,000.
The funds must be used only for the fellow’s salary and benefits.
The application should clearly show how the requested amount will support the fellow during the fellowship period.
Step 8: Attach Required Letters of Support
Applicants must include letters of support from:
- Division Head or Department Chair
- Primary mentor
- Secondary mentor, if applicable
These letters should confirm institutional commitment, mentoring support, and the feasibility of the fellowship programme.
Step 9: Submit the Application
The institution should submit the completed application with all required sections and supporting documents.
The application should not include the names of potential fellows.
Selection Considerations
Applications are likely to be assessed based on institutional capacity, training quality, mentoring strength, and relevance to ATTR cardiac amyloidosis.
Key assessment factors may include:
- Strength of the fellowship training design
- Quality of the mentoring structure
- Institutional experience in ATTR cardiac amyloidosis
- Clinical training resources
- Research development opportunities
- Clear assessment approach
- Feasibility of the six-month programme
- Alignment with eligible funding use
- Diversity, equity and inclusion approach
- Ability to address potential challenges
Tips for a Strong Application
A strong application should clearly show that the institution can deliver high-quality clinical and research training.
Applicants should:
- Present a clear fellowship structure
- Define specific training goals
- Describe patient management exposure
- Include strong mentor roles
- Show relevant ATTR cardiac amyloidosis experience
- Explain research development opportunities
- Provide a realistic assessment approach
- Keep the budget limited to salary and benefits
- Address diversity, equity and inclusion clearly
- Include strong letters of support
- Avoid naming the potential fellow in the application
Common Mistakes to Avoid
Applicants should avoid incomplete or non-compliant applications.
Common mistakes include:
- Naming a potential fellow in the application
- Applying from an institution outside Germany
- Requesting funds for costs other than salary and benefits
- Providing a weak mentoring plan
- Not showing clinical training capacity
- Not demonstrating ATTR cardiac amyloidosis experience
- Missing letters of support
- Failing to address diversity, equity and inclusion
- Not explaining how research development will be supported
- Providing no plan for potential challenges
- Submitting an unclear abstract or training structure
FAQ
1. What is the Pfizer Competitive Fellowship Grant Program?
It is a fellowship grant programme that supports institutional clinical training in ATTR cardiac amyloidosis for healthcare professionals in Germany.
2. How much funding is available?
Grant funding of up to €50,000 is available to support one fellow for up to six months.
3. Who receives the grant funding?
The grant is awarded directly to the institution, not to the individual fellow.
4. What can the funding be used for?
Funding may only be used for the fellow’s salary and benefits.
5. Who can apply?
Eligible applicants are institutions located in Germany with the capacity to provide clinical training and research development in ATTR cardiac amyloidosis.
6. Can institutions name the fellow in the application?
No. Institutions should not include the names of potential fellows in the application.
7. What documents are required?
Applications must include a cover page, fellowship title, participating institution information, abstract, training and research plan, mentoring description, institutional capacity information, challenge mitigation plan, and letters of support from the Division Head or Department Chair and mentor or mentors.
Conclusion
Pfizer’s Competitive Fellowship Grant Program provides German institutions with funding to strengthen clinical training and research capacity in ATTR cardiac amyloidosis. With support of up to €50,000 for one fellow over six months, the programme helps healthcare professionals develop expertise in recognition, diagnosis, treatment, monitoring, patient management, and research. Institutions should submit a clear, compliant, and well-supported application that demonstrates strong mentoring, clinical resources, research capacity, diversity and inclusion, and a focused plan for fellowship implementation.
For more information, visit Pfizer.
